Skip to main content
Erschienen in: Diabetologia 7/2004

01.07.2004 | Article

Impact of diabetes mellitus on long-term outcome after unstable angina and non-ST-segment elevation myocardial infarction treated with a very early invasive strategy

verfasst von: C. Müller, F. J. Neumann, M. Ferenc, A. P. Perruchoud, H. J. Büttner

Erschienen in: Diabetologia | Ausgabe 7/2004

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

We sought to evaluate the impact of diabetes mellitus on long-term outcome in patients with unstable angina and non-ST-segment elevation myocardial infarction treated with a very early invasive strategy.

Methods

We carried out a prospective cohort study in 270 diabetic and 1163 non-diabetic patients with unstable angina and non-ST-segment elevation myocardial infarction. All patients underwent coronary angiography and, if appropriate, subsequent revascularisation within 24 hours of admission. The primary endpoint was all-cause mortality during follow-up for up to 60 months.

Results

Diabetic patients had less favourable baseline characteristics including more advanced coronary artery disease and more severe unstable angina and non-ST-segment elevation myocardial infarction. Percutaneous coronary intervention was performed in 53% of diabetic patients and 56% of non-diabetic patients. Coronary artery bypass grafting was done in 21% of diabetic patients and 12% of non-diabetic patients. In-hospital mortality (4.1% vs 1.3%; hazard ratio 3.47; 95% CI: 1.57 to 7.64; p=0.002) and long-term mortality (9.7% vs 4.9%; hazard ratio 2.11; 95% CI: 1.33 to 3.36; p=0.002) were significantly higher in diabetic patients. After adjustment for differences in baseline characteristics, diabetes mellitus was no longer an independent predictor of long-term mortality (hazard ratio 1.43; 95% CI: 0.74 to 2.78; p=0.292).

Conclusions/interpretation

Diabetic patients treated with a very early invasive strategy for unstable angina and non-ST-segment elevation myocardial infarction have a higher in-hospital and long-term mortality that is largely explained by their less favourable baseline characteristics including more advanced coronary artery disease and more severe unstable angina and non-ST-segment elevation myocardial infarction.
Literatur
1.
Zurück zum Zitat Abbott RD, Donahue RP, Kannel WB, Wilson PW (1988) The impact of diabetes on survival following myocardial infarction in men vs. women: the Framingham Study. JAMA 260:3456–3460CrossRefPubMed Abbott RD, Donahue RP, Kannel WB, Wilson PW (1988) The impact of diabetes on survival following myocardial infarction in men vs. women: the Framingham Study. JAMA 260:3456–3460CrossRefPubMed
2.
Zurück zum Zitat Butler WJ, Osrander LD Jr, Carman WJ, Lamphiear DE (1985) Mortality from coronary heart disease in the Tecumseh Study: long-term effect of diabetes mellitus, glucose intolerance, and other risk factors. Am J Epidemiol 121:541–547CrossRefPubMed Butler WJ, Osrander LD Jr, Carman WJ, Lamphiear DE (1985) Mortality from coronary heart disease in the Tecumseh Study: long-term effect of diabetes mellitus, glucose intolerance, and other risk factors. Am J Epidemiol 121:541–547CrossRefPubMed
3.
Zurück zum Zitat Mueller C, Mc Hodgson JB, Brutsche M et al. (2002) Impact of intracoronary ultrasound guidance on long-term outcome of percutaneous coronary interventions in diabetics—insights from the randomised SIPS trial. Swiss Med Wkly 132:279–284PubMed Mueller C, Mc Hodgson JB, Brutsche M et al. (2002) Impact of intracoronary ultrasound guidance on long-term outcome of percutaneous coronary interventions in diabetics—insights from the randomised SIPS trial. Swiss Med Wkly 132:279–284PubMed
4.
Zurück zum Zitat Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M (1998) Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339:229–34CrossRefPubMed Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M (1998) Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339:229–34CrossRefPubMed
5.
Zurück zum Zitat Gu K, Cowie CC, Harris MI (1999) Diabetes and decline in heart disease mortality in US adults. JAMA 281:1291–1297CrossRefPubMed Gu K, Cowie CC, Harris MI (1999) Diabetes and decline in heart disease mortality in US adults. JAMA 281:1291–1297CrossRefPubMed
6.
Zurück zum Zitat King H, Aubert RE, Herman WH (1998) Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care 21:1414–1431CrossRefPubMed King H, Aubert RE, Herman WH (1998) Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care 21:1414–1431CrossRefPubMed
7.
Zurück zum Zitat Fava S, Azzorpadi J, Agius-Muscat H (1997) Outcome of unstable angina in patients with diabetes mellitus. Diabet Med 14:209–213CrossRefPubMed Fava S, Azzorpadi J, Agius-Muscat H (1997) Outcome of unstable angina in patients with diabetes mellitus. Diabet Med 14:209–213CrossRefPubMed
8.
Zurück zum Zitat Wilcox I, Freedman SB, Allman KC et al. (1991) Prognostic significance of a predischarge exercise test in risk stratification after unstable angina pectoris. J Am Coll Cardiol 18:667–683CrossRef Wilcox I, Freedman SB, Allman KC et al. (1991) Prognostic significance of a predischarge exercise test in risk stratification after unstable angina pectoris. J Am Coll Cardiol 18:667–683CrossRef
9.
Zurück zum Zitat Calvin JE, Klein LW, Van den Berg BJ et al. (1995) Risk stratification in unstable angina: prospective validation of the Braunwald classification. JAMA 273:136–141CrossRefPubMed Calvin JE, Klein LW, Van den Berg BJ et al. (1995) Risk stratification in unstable angina: prospective validation of the Braunwald classification. JAMA 273:136–141CrossRefPubMed
10.
Zurück zum Zitat Gowda MS, Vacek JL, Hallas D (1998) One-year outcomes of diabetic versus nondiabetic patients with non-Q-wave acute myocardial infarction treated with percutaneous transluminal coronary angioplasty. Am J Cardiol 89:1067–1071CrossRef Gowda MS, Vacek JL, Hallas D (1998) One-year outcomes of diabetic versus nondiabetic patients with non-Q-wave acute myocardial infarction treated with percutaneous transluminal coronary angioplasty. Am J Cardiol 89:1067–1071CrossRef
11.
Zurück zum Zitat Malmberg K, Yusuf S, Gerstein HC et al. (2000) Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction. Results of the OASIS (Organization to assess strategies for ischemic syndromes) registry. Circulation 102:1014–1019CrossRefPubMed Malmberg K, Yusuf S, Gerstein HC et al. (2000) Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction. Results of the OASIS (Organization to assess strategies for ischemic syndromes) registry. Circulation 102:1014–1019CrossRefPubMed
12.
Zurück zum Zitat Cannon CP, Weintraub WS, Demopoulos LA et al. (2001) Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein Iib/IIIa inhibitor tirofiban. N Engl J Med 344:1879–1887CrossRefPubMed Cannon CP, Weintraub WS, Demopoulos LA et al. (2001) Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein Iib/IIIa inhibitor tirofiban. N Engl J Med 344:1879–1887CrossRefPubMed
13.
Zurück zum Zitat Norhammar A, Malmberg K, Diderholm E et al. (2004) Diabetes mellitus: the major risk factor in unstable coronary artery disease even after consideration of the extent of coronary artery disease and benefits of revascularization. J Am Coll Cardiol 43:585–591CrossRefPubMed Norhammar A, Malmberg K, Diderholm E et al. (2004) Diabetes mellitus: the major risk factor in unstable coronary artery disease even after consideration of the extent of coronary artery disease and benefits of revascularization. J Am Coll Cardiol 43:585–591CrossRefPubMed
14.
Zurück zum Zitat Neumann FJ, Kastrati A, Pogatsa-Murray G et al. (2003) Evaluation of prolonged antithrombotic pretreatment (“cooling-off strategy”) before intervention in patients with unstable coronary syndromes. A randomized controlled trial. JAMA 290:1593–1599CrossRefPubMed Neumann FJ, Kastrati A, Pogatsa-Murray G et al. (2003) Evaluation of prolonged antithrombotic pretreatment (“cooling-off strategy”) before intervention in patients with unstable coronary syndromes. A randomized controlled trial. JAMA 290:1593–1599CrossRefPubMed
15.
Zurück zum Zitat Braunwald E, Antman EM, Beasley JW et al. (2002) ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation acute myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina). Available from http://www.acc.org/clinical/guidelines/unstable/unstable.pdf, accessed 1 February 2004 Braunwald E, Antman EM, Beasley JW et al. (2002) ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation acute myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina). Available from http://​www.​acc.​org/​clinical/​guidelines/​unstable/​unstable.​pdf, accessed 1 February 2004
16.
Zurück zum Zitat The Task Force on the Management of Acute Coronary Syndromes of the European Society of Cardiology (2002) Management of acute coronary syndromes in patients presenting without ST-segment elevation. Eur Heart J 23:1809–1840CrossRef The Task Force on the Management of Acute Coronary Syndromes of the European Society of Cardiology (2002) Management of acute coronary syndromes in patients presenting without ST-segment elevation. Eur Heart J 23:1809–1840CrossRef
18.
Zurück zum Zitat Van Belle E, Périé M, Braune D et al. (2002) Effects of coronary stenting on vessel patency and long-term clinical outcome after percutaneous coronary revascularization in diabetic patients. J Am Coll Cardiol 40:410–417CrossRef Van Belle E, Périé M, Braune D et al. (2002) Effects of coronary stenting on vessel patency and long-term clinical outcome after percutaneous coronary revascularization in diabetic patients. J Am Coll Cardiol 40:410–417CrossRef
19.
Zurück zum Zitat Detre KM, Guo P, Holubkov R et al. (1999) Coronary revascularization in diabetic patients: a comparison of the randomized and observational components of the Bypass Angioplasty Revascularization Investigation (BARI). Circulation 99:633–40CrossRefPubMed Detre KM, Guo P, Holubkov R et al. (1999) Coronary revascularization in diabetic patients: a comparison of the randomized and observational components of the Bypass Angioplasty Revascularization Investigation (BARI). Circulation 99:633–40CrossRefPubMed
20.
Zurück zum Zitat Conlan MG, Folsom AR, Finch A et al. (1993) Associations of factor VIII and von Willebrand factor with age, race, sex, and risk factors for atherosclerosis: the Atherosclerosis Risk in Communities (ARIC) Study. Thromb Haemost 70:380–385PubMed Conlan MG, Folsom AR, Finch A et al. (1993) Associations of factor VIII and von Willebrand factor with age, race, sex, and risk factors for atherosclerosis: the Atherosclerosis Risk in Communities (ARIC) Study. Thromb Haemost 70:380–385PubMed
21.
Zurück zum Zitat Tracy RP, Bovill EG, Fried LP et al. (1992) The distribution of coagulation factors VII and VIII and fibrinogen in adults over 65 years: results from the Cardiovascular Health Study. Ann Epidemiol 2:509–519CrossRefPubMed Tracy RP, Bovill EG, Fried LP et al. (1992) The distribution of coagulation factors VII and VIII and fibrinogen in adults over 65 years: results from the Cardiovascular Health Study. Ann Epidemiol 2:509–519CrossRefPubMed
22.
Zurück zum Zitat Stegnar M, Pentek M (1993) Fibrinolytic response to venous occlusion in healthy subjects: relationship to age, gender, body weight, blood lipids and insulin. Thromb Res 69:81–92CrossRefPubMed Stegnar M, Pentek M (1993) Fibrinolytic response to venous occlusion in healthy subjects: relationship to age, gender, body weight, blood lipids and insulin. Thromb Res 69:81–92CrossRefPubMed
23.
Zurück zum Zitat Johansson S, Bergstrand R, Schlossman D, Selin K, Vedin A, Wilhelmsson C (1984) Sex differences in cardioangiographic findings after myocardial infarction. Eur Heart J 5:374–381CrossRefPubMed Johansson S, Bergstrand R, Schlossman D, Selin K, Vedin A, Wilhelmsson C (1984) Sex differences in cardioangiographic findings after myocardial infarction. Eur Heart J 5:374–381CrossRefPubMed
24.
Zurück zum Zitat Levenson J, Pessana F, Gariepy J, Armentano R, Simon A (2001) Gender differences in wall shear-mediated brachial artery vasoconstriction and vasodilation. J Am Coll Cardiol 38:1668–1674CrossRefPubMed Levenson J, Pessana F, Gariepy J, Armentano R, Simon A (2001) Gender differences in wall shear-mediated brachial artery vasoconstriction and vasodilation. J Am Coll Cardiol 38:1668–1674CrossRefPubMed
25.
Zurück zum Zitat Mueller C, Neumann FJ, Roskamm H et al. (2002) Women do have an improved long-term outcome after non-ST-elevation acute coronary syndromes treated very early and predominately with percutaneous coronary intervention: a prospective study in 1450 consecutive patients. J Am Coll Cardiol 40:245–250CrossRefPubMed Mueller C, Neumann FJ, Roskamm H et al. (2002) Women do have an improved long-term outcome after non-ST-elevation acute coronary syndromes treated very early and predominately with percutaneous coronary intervention: a prospective study in 1450 consecutive patients. J Am Coll Cardiol 40:245–250CrossRefPubMed
Metadaten
Titel
Impact of diabetes mellitus on long-term outcome after unstable angina and non-ST-segment elevation myocardial infarction treated with a very early invasive strategy
verfasst von
C. Müller
F. J. Neumann
M. Ferenc
A. P. Perruchoud
H. J. Büttner
Publikationsdatum
01.07.2004
Verlag
Springer Berlin Heidelberg
Erschienen in
Diabetologia / Ausgabe 7/2004
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-004-1450-3

Weitere Artikel der Ausgabe 7/2004

Diabetologia 7/2004 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.